×
About 397 results

ALLMedicine™ Alopecia Universalis Center

Research & Reviews  179 results

Alopecia universalis: a patient's perspective of the cumulative life course impairment.
https://doi.org/10.1111/ced.14596
Clinical and Experimental Dermatology; Burns LJ, Flanagan KE et. al.

Mar 19th, 2021 - Alopecia universalis: a patient's perspective of the cumulative life course impairment.|2021|Burns LJ,Flanagan KE,Pathoulas JT,Ellison A,Mesinkovska N,|

Therapeutic management in pediatric alopecia areata: a systematic review.
https://doi.org/10.1111/jdv.17187
Journal of the European Academy of Dermatology and Venere... Waśkiel-Burnat A, Kołodziejak M et. al.

Feb 25th, 2021 - Alopecia areata is the third-most-common cause of dermatology consultations in children but the treatment of pediatric alopecia areata remains challenging. A systematic review of the literature about the treatment of alopecia areata in children (≤...

Tofacitinib as Treatment for Nail Lichen Planus Associated With Alopecia Universalis.
https://doi.org/10.1001/jamadermatol.2020.4555
JAMA Dermatology; Iorizzo M, Haneke E

Jan 6th, 2021 - Tofacitinib as Treatment for Nail Lichen Planus Associated With Alopecia Universalis.|2021|Iorizzo M,Haneke E,|

Squaric acid dibutyl ester for the treatment of alopecia areata: A retrospective evalua...
https://doi.org/10.1111/dth.14726
Dermatologic Therapy; Losol E, Şentürk N

Dec 30th, 2020 - Squaric acid dibutyl ester (SADBE) as topical immunotherapy is a good alternative in patients with refractory alopecia areata. In this study, we aimed to evaluate the effectiveness of SADBE treatment in alopecia areata (AA) and alopecia totalis/al...

Efficacy of systemic minoxidil and tofacitinib combination in treatment-resistant alope...
https://doi.org/10.1111/jocd.13812
Journal of Cosmetic Dermatology REFERENCES; Dincer D, Tanacan E et. al.

Oct 24th, 2020 - Alopecia areata (AA) is an autoimmune nonscarring alopecic disorder, which presents with varying amounts of hair loss, ranging from focal patchy loss to entire scalp and body hair loss. Treatment of AA is a challenging issue within dermatology pra...

see more →

Clinicaltrials.gov  193 results

Alopecia universalis: a patient's perspective of the cumulative life course impairment.
https://doi.org/10.1111/ced.14596
Clinical and Experimental Dermatology; Burns LJ, Flanagan KE et. al.

Mar 19th, 2021 - Alopecia universalis: a patient's perspective of the cumulative life course impairment.|2021|Burns LJ,Flanagan KE,Pathoulas JT,Ellison A,Mesinkovska N,|

Therapeutic management in pediatric alopecia areata: a systematic review.
https://doi.org/10.1111/jdv.17187
Journal of the European Academy of Dermatology and Venere... Waśkiel-Burnat A, Kołodziejak M et. al.

Feb 25th, 2021 - Alopecia areata is the third-most-common cause of dermatology consultations in children but the treatment of pediatric alopecia areata remains challenging. A systematic review of the literature about the treatment of alopecia areata in children (≤...

Tofacitinib as Treatment for Nail Lichen Planus Associated With Alopecia Universalis.
https://doi.org/10.1001/jamadermatol.2020.4555
JAMA Dermatology; Iorizzo M, Haneke E

Jan 6th, 2021 - Tofacitinib as Treatment for Nail Lichen Planus Associated With Alopecia Universalis.|2021|Iorizzo M,Haneke E,|

Squaric acid dibutyl ester for the treatment of alopecia areata: A retrospective evalua...
https://doi.org/10.1111/dth.14726
Dermatologic Therapy; Losol E, Şentürk N

Dec 30th, 2020 - Squaric acid dibutyl ester (SADBE) as topical immunotherapy is a good alternative in patients with refractory alopecia areata. In this study, we aimed to evaluate the effectiveness of SADBE treatment in alopecia areata (AA) and alopecia totalis/al...

Efficacy of systemic minoxidil and tofacitinib combination in treatment-resistant alope...
https://doi.org/10.1111/jocd.13812
Journal of Cosmetic Dermatology REFERENCES; Dincer D, Tanacan E et. al.

Oct 24th, 2020 - Alopecia areata (AA) is an autoimmune nonscarring alopecic disorder, which presents with varying amounts of hair loss, ranging from focal patchy loss to entire scalp and body hair loss. Treatment of AA is a challenging issue within dermatology pra...

see more →

News  25 results

JAK Inhibitors Promising for Alopecia Areata
https://www.staging.medscape.com/viewarticle/902077

Sep 16th, 2018 - PARIS — Two investigational oral Janus kinase (JAK) inhibitors are safe and effective for patients with moderate to severe hair loss, according to 24-week interim findings from a randomized, double-blind, placebo-controlled, multicenter phase 2 tr...

JAK Inhibitors Promising for Alopecia Areata
https://www.medscape.com/viewarticle/902077

Sep 16th, 2018 - PARIS — Two investigational oral Janus kinase (JAK) inhibitors are safe and effective for patients with moderate to severe hair loss, according to 24-week interim findings from a randomized, double-blind, placebo-controlled, multicenter phase 2 tr...

JAK inhibitors emerge as promising alopecia treatment
https://www.mdedge.com/familymedicine/article/174331/hair-nails/jak-inhibitors-emerge-promising-alopecia-treatment
Dermatology News; Doug Brunk

Sep 9th, 2018 - LAKE TAHOE, CALIF. – After Brett King, MD, PhD, and his wife and collaborator, Brittany G.

JAK inhibitors look good for severe alopecia areata treatment
https://www.mdedge.com/familymedicine/article/157463/dermatology/jak-inhibitors-look-good-severe-alopecia-areata-treatment
Pediatric News; Catherine Cooper Nellist

Jan 31st, 2018 - Janus kinase inhibitors look promising in the treatment of severe alopecia areata, particularly in adolescents, said Lucy Yichu Liu, MD, and Brett Andrew King, MD, of Yale University, New Haven, Conn. Standard medical therapies for alopecia areata.

Alopecia patients share their struggles
https://www.mdedge.com/familymedicine/article/147460/hair-nails/alopecia-patients-share-their-struggles
Dermatology News; Heidi Splete

Sep 19th, 2017 - SILVER SPRING, MD. – Alopecia areata patients struggle as much, if not more so, with the social and emotional challenges of the disease as with the physical challenges, according to patients and others who spoke at a public meeting on alopecia are.

see more →